7 × age)]  and SB202190 a Polar Heart Rate Monitor (Polar USA, Inc., NY). At the beginning of the study (weeks 1 to 4), each exercise session ran for 25 min duration and corresponded to 60% of the subject’s HRmax. Training duration and intensity increased incrementally at week 4, 7 and 10 by 5 min and 5% HRmax. As such, by week 10, each subject was exercising for a 40 min duration at an intensity of 75% HRmax. ADF and control subjects were asked to maintain their regular activity habits during the study. Weight loss assessment Body weight was measured weekly to the nearest 0.25 kg in the fasted state using a balance beam
scale (HealthOMeter, Sunbeam Products, Boca Raton, FL). Waist circumference was measured by a flexible tape to the nearest 0.1 cm, midway between the lower costal margin and super iliac crest
during a period of expiration. Adherence to the ADF diet and exercise selleck kinase inhibitor protocol During the controlled feeding phase (week 1–4), subjects were instructed to eat only the fast day food provided, and to report any extra food item consumed using an “Extra food log”. The log was collected and reviewed by study personnel each week. If the log indicated that the subject ate an extra food item on a fast day, that day was labeled as “not adherent”. Exercise compliance was assessed by recording attendance at each supervised exercise session. If an exercise session was missed, the subject was required to make up for the missed session that same week. Physical activity maintenance assessment Habitual, free-living physical activity was assessed by a pedometer (Digiwalker SW-200, Yamax Corporation, Tokyo, Japan SW). Subjects wore the pedometer for a 7-d period at week 1 and 12. The pedometer was worn attached to the participant’s waistband during CHIR98014 chemical structure waking
hours (except while bathing or swimming), and reset to Atezolizumab clinical trial zero each morning. Number of daily steps were recorded in a pedometer log provided, and the log was collected by study personnel at the weigh-in each week. No subjects were enrolled in an exercise class, and all participants were asked to refrain from joining any exercise programs during the course of the study. Eating behavior assessment A validated visual analog scale (VAS)  was used to measure hunger, fullness, and satisfaction with the ADF diet. The scale was completed on each fast day (before bedtime). In brief, the VAS consisted of 100-mm lines, and subjects were asked to make a vertical mark across the line corresponding to their feelings from 0 (not at all) to 100 (extremely) for hunger, satisfaction, or fullness. Quantification was performed by measuring the distance from the left end of the line to the vertical mark.